Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Rheumatic Heart Disease I: Introduction01:23

Rheumatic Heart Disease I: Introduction

558
Rheumatic heart disease or RHD is a chronic condition that results from rheumatic fever, causing permanent damage to the heart valves.Etiology and Risk FactorsIt primarily arises from rheumatic fever, an inflammatory disease that can develop after untreated or inadequately treated group A streptococcal (GAS) pharyngitis. Streptococcus spreads through direct contact with oral or respiratory secretions. While the bacteria are the causative agents, factors like malnutrition, overcrowding, poor...
558
Rheumatic Heart Disease IV: Nursing Management01:20

Rheumatic Heart Disease IV: Nursing Management

346
AssessmentA comprehensive assessment is essential in managing a patient with rheumatic heart disease (RHD). Begin with obtaining a detailed medical history, including recent streptococcal infections, a history of rheumatic fever, or previously diagnosed rheumatic heart disease. Assess the patient for symptoms such as fever, chest pain, widespread joint pain (arthralgia), tachycardia, pericardial friction rub, muffled heart sounds, heart murmurs, peripheral edema, subcutaneous nodules, and...
346
Rheumatic Heart Disease III: Medical Management01:21

Rheumatic Heart Disease III: Medical Management

380
Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...
380
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies01:22

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

667
The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
667
Types of RNA01:23

Types of RNA

73.0K
Overview
Three main types of RNA are involved in protein synthesis: messenger RNA (mRNA), transfer RNA (tRNA), and ribosomal RNA (rRNA). These RNAs perform diverse functions and can be broadly classified as protein-coding or non-coding RNA. Non-coding RNAs play important roles in the regulation of gene expression in response to developmental and environmental changes. Non-coding RNAs in prokaryotes can be manipulated to develop more effective antibacterial drugs for human or animal use.
RNA...
73.0K
Types of Hormones02:13

Types of Hormones

84.2K
Hormones can be classified into three main types based on their chemical structures: steroids, peptides, and amines. Their actions are mediated by the specific receptors they bind to on target cells.
84.2K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Lectin pathway of complement in SLE: MAP-1 as a marker of haematological manifestations and elevated type I interferon activity.

Lupus science & medicine·2026
Same author

Co-Occurrence of Endometriosis with Systemic Lupus Erythematosus: Genetic Aspects.

International journal of molecular sciences·2025
Same author

Co-occurrence of endometriosis with psoriasis and psoriatic arthritis: Genetic insights (Review).

Experimental and therapeutic medicine·2025
Same author

Role of interleukin-16 in human diseases: a novel potential therapeutic target.

Frontiers in immunology·2025
Same author

Neuropsychiatric manifestations in systemic lupus erythematosus and Sjogren's disease.

Autoimmunity reviews·2025
Same author

TLR7/8 Activation in Immune Cells and Muscle by RNA-Containing Immune Complexes: Role in Inflammation and the Pathogenesis of Myositis.

Arthritis & rheumatology (Hoboken, N.J.)·2024
Same journal

Joint-specific susceptibility to inflammation is determined in utero.

Nature reviews. Rheumatology·2026
Same journal

Time to rethink the treatment of palindromic rheumatism.

Nature reviews. Rheumatology·2026
Same journal

Sensory nerves protect against tendon degeneration.

Nature reviews. Rheumatology·2026
Same journal

Publisher Correction: TLR7 in systemic lupus erythematosus: genetics and emerging therapies.

Nature reviews. Rheumatology·2026
Same journal

TLR7 in systemic lupus erythematosus: genetics and emerging therapies.

Nature reviews. Rheumatology·2026
Same journal

Lung disease in rheumatoid arthritis.

Nature reviews. Rheumatology·2026
See all related articles

Related Experiment Video

Updated: Feb 13, 2026

High-throughput Quantitative Real-time RT-PCR Assay for Determining Expression Profiles of Types I and III Interferon Subtypes
10:00

High-throughput Quantitative Real-time RT-PCR Assay for Determining Expression Profiles of Types I and III Interferon Subtypes

Published on: March 24, 2015

13.8K

Type I interferon in rheumatic diseases.

Theresa L Wampler Muskardin1,2, Timothy B Niewold1,3

  • 1Colton Center for Autoimmunity, Department of Medicine, New York University School of Medicine, New York, NY, USA.

Nature Reviews. Rheumatology
|March 22, 2018
PubMed
Summary
This summary is machine-generated.

The type I interferon pathway is involved in rheumatic diseases like lupus and rheumatoid arthritis. Persistent activation of this pathway in patients may predict treatment response, with new therapies showing promise.

More Related Videos

A High-Throughput Electrochemiluminescence 7-Plex Assay Simultaneously Screening for Type 1 Diabetes and Multiple Autoimmune Diseases
06:50

A High-Throughput Electrochemiluminescence 7-Plex Assay Simultaneously Screening for Type 1 Diabetes and Multiple Autoimmune Diseases

Published on: May 29, 2020

3.1K
Imaging of In Situ Interferon Gamma Production in the Mouse Spleen following Listeria monocytogenes Infection
09:11

Imaging of In Situ Interferon Gamma Production in the Mouse Spleen following Listeria monocytogenes Infection

Published on: July 16, 2019

9.7K

Related Experiment Videos

Last Updated: Feb 13, 2026

High-throughput Quantitative Real-time RT-PCR Assay for Determining Expression Profiles of Types I and III Interferon Subtypes
10:00

High-throughput Quantitative Real-time RT-PCR Assay for Determining Expression Profiles of Types I and III Interferon Subtypes

Published on: March 24, 2015

13.8K
A High-Throughput Electrochemiluminescence 7-Plex Assay Simultaneously Screening for Type 1 Diabetes and Multiple Autoimmune Diseases
06:50

A High-Throughput Electrochemiluminescence 7-Plex Assay Simultaneously Screening for Type 1 Diabetes and Multiple Autoimmune Diseases

Published on: May 29, 2020

3.1K
Imaging of In Situ Interferon Gamma Production in the Mouse Spleen following Listeria monocytogenes Infection
09:11

Imaging of In Situ Interferon Gamma Production in the Mouse Spleen following Listeria monocytogenes Infection

Published on: July 16, 2019

9.7K

Area of Science:

  • Immunology
  • Rheumatology

Background:

  • Type I interferons are crucial for antiviral defense but are persistently activated in many rheumatic diseases.
  • Genetic variations and aberrant immune activation (e.g., via Toll-like receptors) contribute to dysregulated type I interferon pathways in rheumatic conditions.

Purpose of the Study:

  • To review the multifaceted roles of the type I interferon system in the pathogenesis of various rheumatic diseases.
  • To explore the clinical implications of type I interferon pathway dysregulation, including its potential as a biomarker for therapeutic response.

Main Methods:

  • Literature review of studies investigating type I interferon pathways in rheumatic diseases.
  • Analysis of genetic, immunological, and clinical data related to type I interferon activity.

Main Results:

  • The type I interferon pathway is implicated in systemic lupus erythematosus, Sjögren syndrome, myositis, systemic sclerosis, and rheumatoid arthritis.
  • Persistent activation of this pathway is observed in significant patient subgroups and is influenced by genetic factors and innate immune sensing.

Conclusions:

  • Dysregulation of the type I interferon pathway is a common feature across several rheumatic diseases.
  • Targeting the type I interferon pathway represents a promising therapeutic strategy, with ongoing clinical trials yielding positive results.